N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide
TL;DR: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide (CAS 902012-52-6) is a chemical compound with molecular formula C22H21NO6 and molecular weight 395.14 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxochromen-3-yl)propanamide
Also Known As: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide, N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxochromen-3-yl)propanamide, N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide
| Molecular Formula | C22H21NO6 |
|---|---|
| Molecular Weight | 395.14 g/mol |
| LogP | 3.45794 |
| Topological Polar Surface Area | 98.0 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Exact Mass | 395.1369 |
| Heavy Atoms | 29 |
| Complexity | 1164.1567 |
Chemical Identifiers
| CAS Number | 902012-52-6 |
|---|---|
| SMILES | CC1=C(C(=O)OC2=C1C=CC(=C2C)O)CCC(=O)NC3=CC4=C(C=C3)OCCO4 |
Product Overview
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide (CAS 902012-52-6), with molecular formula C22H21NO6 and molecular weight 395.14 g/mol. IUPAC: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxochromen-3-yl)propanamide.
Chemical Property Profile of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide
Property Insights of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide
The XLogP value of 3.45794 indicates that N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 98.0 Ų falls within the moderate polarity range, balancing permeability and solubility for N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide. Following Lipinski's Rule of Five, N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide has 2 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide?
The CAS number of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide is 902012-52-6.
What is the molecular formula of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide?
The molecular formula of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide is C22H21NO6.
What is the molecular weight of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide?
The molecular weight of N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide is 395.14 g/mol.
Where can I buy N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide?
You can request a quote for N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide?
Yes, KEHONG BIO provides custom synthesis services for N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(7-hydroxy-4,8-dimethyl-2-oxo-2H-chromen-3-yl)propanamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.